XFOR
X4 Pharmaceuticals, IncCompany with tickers: XFOR
CIK
1501697
CUSIP
98420X202
Shares Outstanding
94,319,696
13F Activity (30d)
66 filings
65 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2020-01-10 | 2020-01-09 | |
| 8-K | 2020-02-13 | 2020-02-10 | |
| 8-K | 2020-03-12 | 2020-03-06 | |
| 10-K | 2020-03-12 | 2019-12-31 | |
| 8-K | 2020-03-17 | 2020-03-13 | |
| 8-K | 2020-03-20 | 2020-03-18 | |
| 10-Q | 2020-05-07 | 2020-03-31 | |
| 8-K | 2020-05-07 | 2020-05-06 | |
| 8-K | 2020-06-11 | 2020-06-10 | |
| 8-K | 2020-07-30 | 2020-07-29 | |
| 10-Q | 2020-08-04 | 2020-06-30 | |
| 8-K | 2020-09-11 | — | |
| 8-K | 2020-10-01 | 2020-09-25 | |
| 8-K | 2020-10-07 | — | |
| 8-K | 2020-10-16 | 2020-10-14 | |
| 8-K | 2020-11-05 | — | |
| 10-Q | 2020-11-05 | 2020-09-30 | |
| 8-K | 2020-12-23 | 2020-12-21 | |
| 8-K | 2021-01-08 | — | |
| 8-K | 2021-03-04 | — | |
| 10-K | 2021-03-19 | 2020-12-31 | |
| 8-K | 2021-03-19 | 2021-03-18 | |
| 8-K | 2021-04-09 | — | |
| 8-K | 2021-05-06 | — | |
| 10-Q | 2021-05-06 | 2021-03-31 | |
| 8-K | 2021-06-07 | — | |
| 8-K | 2021-06-11 | — | |
| 8-K | 2021-06-28 | — | |
| 8-K | 2021-07-15 | — | |
| 8-K | 2021-07-23 | 2021-07-20 | |
| 10-Q | 2021-08-03 | 2021-06-30 | |
| 8-K | 2021-08-03 | — | |
| 8-K | 2021-08-06 | — | |
| 8-K | 2021-09-10 | — | |
| 8-K | 2021-10-19 | 2021-10-14 | |
| 8-K | 2021-11-04 | — | |
| 10-Q | 2021-11-04 | 2021-09-30 | |
| 8-K | 2021-11-05 | — | |
| 8-K | 2021-11-12 | 2021-11-11 | |
| 8-K | 2021-11-15 | — | |
| 8-K | 2021-12-13 | — | |
| 8-K | 2022-01-14 | — | |
| 8-K | 2022-01-14 | 2022-01-13 | |
| 8-K | 2022-01-25 | — | |
| 8-K/A | 2022-01-26 | 2022-01-25 | |
| 8-K | 2022-02-09 | — | |
| 8-K | 2022-03-03 | — | |
| 8-K | 2022-03-17 | — | |
| 10-K | 2022-03-17 | 2021-12-31 | |
| 10-Q | 2022-05-12 | 2022-03-31 |
Showing 1–50 of 129 filings